Toby Prout

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors

Robert Brown, N. Tunariu, C. Yap, 2022, Journal for ImmunoTherapy of Cancer.

Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia

A. Beggs, J. James, D. Morton, 2018, Inflammatory bowel diseases.

Triplet therapy with palbociclib, taselisib and fulvestrant in PIK3CA mutant breast cancer and doublet palbociclib and taselisib in pathway mutant solid cancers.

H. Gevensleben, M. Hubank, Juanita Lopez, 2020, Cancer discovery.

A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

N. Tunariu, Juanita Lopez, U. Banerji, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

N. Tunariu, A. Stathis, R. Ruddle, 2023, Nature.